Ulodesine hemiglutarate (Helix BioPharma)

N/A

Report date: 2025/06/24 11:24:31
NME

Base Information

Drug NameUlodesine hemiglutarate (Helix BioPharma)
Drug Alias NameLEUMUNALR-09
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurine nucleoside phosphorylase inhibitorsImmune checkpoint modulators
TargetsPurine nucleoside phosphorylase
Therapy Area/IndicationsHematologic NeoplasmsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLaevoroc Immunology AG
China Registration ClassN/A

Develop Information

Active CompaniesLaevoroc Immunology AGHelix Biopharma Corp
Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A